1
|
Sangare M, Doumbia F, Sidibe O, Oumar AA, Bah S, Kouyate M, Diakite SS, Traore K, Karembe A, Haidara MS, Coulibaly SP, Coulibaly S, Togora A, Dolo H, Traore D, Doumbia S, Diakite M, Maiga Y, Diawara A, Kuate C, Kim HG, Awandare GA. Epilepsy Research in Mali: A Pilot Pharmacokinetics Study on First-Line Antiepileptic Drug Treatment. J Epilepsy Res 2020; 10:31-39. [PMID: 32983953 PMCID: PMC7494886 DOI: 10.14581/jer.20006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2020] [Revised: 04/09/2020] [Accepted: 05/04/2020] [Indexed: 02/05/2023] Open
Abstract
BACKGROUND AND PURPOSE The indication and benefit of plasma level of antiepileptic (AEDs) has been debating in the monitoring of people living with epilepsy and the epilepsy treatment gap has largely been documented in developed countries. This study was aimed to highlight the epilepsy treatment gap between rural and urban Mali. METHODS We conducted a pilot study on AEDs treatment from September 2016 to May 2019. For 6 months, 120 children and young adults living with epilepsy (rural site, 90; urban site, 30) received phenobarbital, valproic acid and/or carbamazepine. At our rural study site, we determined the AED plasma levels, monitored the frequency, severity and the duration of seizure, and administered monthly the McGill quality of life questionnaire. At our urban study site, each patient underwent an electroencephalogram and brain computed tomography scan without close monitoring. RESULTS At the rural study site, patients were mostly on monotherapy; AED levels at 1 month (M1) (n=90) and at 3 months (M3) (n=27) after inclusion were normal in 50% at M1 versus 55.6% at M3, low in 42.2% at M1 versus 33.3% at M3 and high in 7.8% at M1 versus 11.1% at M3. AED levels at M1 and at M3 were significantly different p<0.0001. By M3, seizures (n=90) were <1/month in 26.7%, and lasted less than 1 minute in 16.7%. After a yearlong follow up, all 90 patients reported a good or excellent quality of life. At our urban study site, patients (n=30) were on carbamazepine and valproid acid in 66.67% and monotherapy (carbamazepine) in 33.33%. By November 2018, only six out 30 patients (on bi-therapy) were still taking their medications. CONCLUSIONS Epilepsy diagnostic and treatment are a real concern in Mali. Our data showed appropriate AED treatment with close follow up resulted in a better quality of life of patients in rural Mali. We will promote the approach of personalized medicine in AED treatment in Mali.
Collapse
Affiliation(s)
- Modibo Sangare
- Faculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar
- West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra, Ghana, State of Qatar
| | - Fatoumata Doumbia
- Faculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar
| | - Oumar Sidibe
- Faculty of Pharmacy, University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, State of Qatar
| | - Aboucacar Alassane Oumar
- Faculty of Pharmacy, University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, State of Qatar
| | - Sekou Bah
- Faculty of Pharmacy, University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, State of Qatar
| | - Modibo Kouyate
- African Center of Excellence in Bio-informatics (ACE), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamakom, State of Qatar
| | - Seidina S. Diakite
- Faculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar
- Faculty of Pharmacy, University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, State of Qatar
| | - Karim Traore
- Faculty of Pharmacy, University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, State of Qatar
| | - Adama Karembe
- Faculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar
| | - Mohamed S. Haidara
- Faculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar
| | - Souleymane P. Coulibaly
- Faculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar
| | - Souleymane Coulibaly
- Faculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar
| | - Arouna Togora
- Faculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar
| | - Housseini Dolo
- Faculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar
| | - Drissa Traore
- Faculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar
| | - Seydou Doumbia
- Faculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar
| | - Mahamadou Diakite
- Faculty of Pharmacy, University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, State of Qatar
| | - Youssoufa Maiga
- Faculty of Medicine and Odontostomatology (FMOS), University of Sciences, Techniques & Technologies of Bamako (USTTB), Bamako, Mali, State of Qatar
| | - Amadou Diawara
- Algi Biomedical Analysis Lab, Bamako, Mali, State of Qatar
| | - Callixte Kuate
- Central Neurology Hospital, Yaounde, Cameroun, State of Qatar
| | - Hyung-Goo Kim
- Neurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI), Doha, State of Qatar
| | - Gordon A. Awandare
- West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra, Ghana, State of Qatar
| |
Collapse
|